Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy.
González-Cruz C, Muñoz-Couselo E, Ortiz-Velez C, Ferrer B, García-Patos V, Ferrándiz-Pulido C. González-Cruz C, et al. Among authors: ortiz velez c. JAAD Case Rep. 2024 Mar 1;46:67-69. doi: 10.1016/j.jdcr.2024.02.011. eCollection 2024 Apr. JAAD Case Rep. 2024. PMID: 38577496 Free PMC article. No abstract available.
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.
Riveiro-Barciela M, Barreira-Díaz A, Salcedo MT, Callejo-Pérez A, Muñoz-Couselo E, Iranzo P, Ortiz-Velez C, Cedrés S, Díaz-Mejía N, Ruiz-Cobo JC, Morales R, Aguilar-Company J, Zamora E, Oliveira M, Sanz-Martínez MT, Viladomiu L, Martínez-Gallo M, Felip E, Buti M. Riveiro-Barciela M, et al. Among authors: ortiz velez c. Aliment Pharmacol Ther. 2024 Apr;59(7):865-876. doi: 10.1111/apt.17898. Epub 2024 Feb 7. Aliment Pharmacol Ther. 2024. PMID: 38327102
Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data.
Cañueto J, Muñoz-Couselo E, Cardona-Machado C, Becerril-Andrés S, Martín-Vallejo J, Serra-Guillén C, Soria A, Serrano-Domingo JJ, Ortiz-Velez C, Lostes J, García-Castaño A, Puig S, Fernández de Misa R, Medina J, Aguado C, Ayala de Miguel P, Navarro-Navarro I, Masferrer E, Delgado M, Bellido-Hernández L, Sanmartin O. Cañueto J, et al. Among authors: ortiz velez c. J Eur Acad Dermatol Venereol. 2024 Aug;38(8):e666-e670. doi: 10.1111/jdv.19821. Epub 2024 Feb 3. J Eur Acad Dermatol Venereol. 2024. PMID: 38308557 No abstract available.
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate.
Aceituno L, Bañares J, Ruiz-Ortega L, Callejo-Pérez A, Muñoz-Couselo E, Ortiz-Velez C, Díaz-Mejía N, Barreira-Díaz A, Carreras MJ, Farriols A, Buti M, Riveiro-Barciela M. Aceituno L, et al. Among authors: ortiz velez c. Front Med (Lausanne). 2022 Jul 15;9:916213. doi: 10.3389/fmed.2022.916213. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35911389 Free PMC article.
Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Riveiro-Barciela M, Barreira-Díaz A, Vidal-González J, Muñoz-Couselo E, Martínez-Valle F, Viladomiu L, Mínguez B, Ortiz-Velez C, Castells L, Esteban R, Buti M. Riveiro-Barciela M, et al. Among authors: ortiz velez c. Liver Int. 2020 Aug;40(8):1906-1916. doi: 10.1111/liv.14489. Epub 2020 Jun 3. Liver Int. 2020. PMID: 32329119